Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status:
Completed
Trial end date:
2013-11-06
Target enrollment:
Participant gender:
Summary
The goal of the current study is to determine efficacy and safety of once-weekly aripiprazole
in reducing Total Tic Severity (TTS) score in children and adolescents with Tourette's
Disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.